Nanotargeted Radionuclides for cancer nuclear imaging and internal radiotherapy

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Ting, Gann ^a   Chang, Chih Hsien ^b,c   Wang, Hsin Ell ^c   Lee, Te Wei ^b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIUM 225; BIOLOGICAL MARKER; BORON 10; BROMINE 76; COPPER 64; COPPER 67; FLUORINE 18; GALLIUM 67; INDIUM 111; IODINE 123; IODINE 124; IODINE 131; LUTETIUM 177; NANOCARRIER; NANOPARTICLE; RADIOISOTOPE; RHENIUM 186; RHENIUM 188; TECHNETIUM 99M; YTTRIUM 90;

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; DIAGNOSTIC IMAGING; HUMAN; NANOMEDICINE; NANOTOXICOLOGY; NEOPLASM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; DIAGNOSTIC IMAGING; HUMANS; MOLECULAR TARGETED THERAPY; NANOMEDICINE; NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY;

EID: 77956739230     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/953537     Document Type: Review

References (111)

1. Strebhardt K., Ullrich A., Paul Ehrlich's magic bullet concept: 100 years of progress Nature Reviews Cancer 2008 8 6 473 480
2. Adams G. P., Weiner L. M., Monoclonal antibody therapy of cancer Nature Biotechnology 2005 23 9 1147 1157
3. Reichert J. M., Valge-Archer V. E., Development trends for monoclonal antibody cancer therapeutics Nature Reviews Drug Discovery 2007 6 5 349 356
4. Carter P. J., Potent antibody therapeutics by design Nature Reviews Immunology 2006 6 5 343 357
5. Newsome B. W., Ernstoff M. S., The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived? British Journal of Clinical Pharmacology 2008 66 1 6 19
6. Gabizon A., Shmeeda H., Barenholz Y., Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies Clinical Pharmacokinetics 2003 42 5 419 436
7. Allen T. M., Cullis P. R., Drug delivery systems: entering the mainstream Science 2004 303 5665 1818 1822
8. Davis M. E., Chen Z., Shin D. M., Nanoparticle therapeutics: an emerging treatment modality for cancer Nature Reviews Drug Discovery 2008 7 9 771 782
9. Ferrari M., Cancer nanotechnology: opportunities and challenges Nature Reviews Cancer 2005 5 3 161 171
10. Lammers T., Hennink W. E., Storm G., Tumour-targeted nanomedicines: principles and practice British Journal of Cancer 2008 99 3 392 397
11. Kairemo K., Erba P., Bergstrm K., Pauwels E. K. J., Nanoparticles in cancer Current Radiopharmaceuticals 2008 1 1 30 36
12. Bawarski W. E., Chidlowsky E., Bharali D. J., Mousa S. A., Emerging nanopharmaceuticals Nanomedicine 2008 4 4 273 282
13. Sanhai W. R., Sakamoto J. H., Canady R., Ferrari M., Seven challenges for nanomedicine Nature Nanotechnology 2008 3 5 242 244
14. Milenic D. E., Brady E. D., Brechbiel M. W., Antibody-targeted radiation cancer therapy Nature Reviews Drug Discovery 2004 3 6 488 499
15. Wong J. Y. C., Systemic targeted radionuclide therapy: potential new areas International Journal of Radiation Oncology Biology Physics 2006 66 2, supplement S74 S82
16. Macklis R. M., Pohlman B., Radioimmunotherapy for non-Hodgkin's lymphoma: a review for radiation oncologists International Journal of Radiation Oncology Biology Physics 2006 66 3 833 841
17. Davies A. J., Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I131 tositumomab Oncogene 2007 26 25 3614 3628
18. Jacene H. A., Filice R., Kasecamp W., Wahl R. L., Comparison of Y90 -ibritumomab tiuxetan and I131-tositumomab in clinical practice Journal of Nuclear Medicine 2007 48 11 1767 1776
19. Britz-Cunningham S. H., Adelstein S. J., Molecular targeting with radionuclides: state of the science Journal of Nuclear Medicine 2003 44 12 1945 1961
20. Hamoudeh M., Kamleh M. A., Diab R., Fessi H., Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer Advanced Drug Delivery Reviews 2008 60 12 1329 1346
21. Mitra A., Nan A., Line B. R., Ghandehari H., Nanocarriers for nuclear imaging and radiotherapy of cancer Current Pharmaceutical Design 2006 12 36 4729 4749
22. Liu Y., Miyoshi H., Nakamura M., Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles International Journal of Cancer 2007 120 12 2527 2537
23. Sofou S., Surface-active liposomes for targeted cancer therapy Nanomedicine 2007 2 5 711 724
24. Ogihara I., Kojima S., Jay M., Differential uptake of gallium-67-labeled liposomes between tumors and inflammatory lesions in rats Journal of Nuclear Medicine 1986 27 8 1300 1307
25. Klibanov A. L., Maruyama K., Torchilin V. P., Huang L., Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Letters 1990 268 1 235 237
26. Papahadjopoulos D., Allen T. M., Gabizon A., Mayhew E., Matthay K., Huang S. K., Lee K.-D., Woodle M. C., Lasic D. D., Redemann C., Martin F. J., Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proceedings of the National Academy of Sciences of the United States of America 1991 88 24 11460 11464
27. Lasic D., Doxorubicin in sterically stabilized Nature 1996 380 6574 561 562
28. Phillips W. T., Delivery of gamma-imaging agents by liposomes Advanced Drug Delivery Reviews 1999 37 13 13 32
29. Boerman O. C., Laverman P., Oyen W. J. G., Corstens F. H. M., Storm G., Radiolabeled liposomes for scintigraphic imaging Progress in Lipid Research 2000 39 5 461 475
30. Bao A., Goins B., Klipper R., Negrete G., Mahindaratne M., Phillips W. T., A novel liposome radiolabeling method using T99mc -SNS/S complexes: in vitro and in vivo evaluation Journal of Pharmaceutical Sciences 2003 92 9 1893 1904
31. Phillips W. T., Goins B. A., Bao A., Radioactive liposomes Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology 2009 1 1 69 83
32. Jarrett B. R., Gustafsson B., Kukis D. L., Louie A. Y., Synthesis of C64u -labeled magnetic nanoparticles for multimodal imaging Bioconjugate Chemistry 2008 19 7 1496 1504
33. Lee H.-Y., Li Z., Chen K., Hsu A. R., Xu C., Xie J., Sun S., Chen X., PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles Journal of Nuclear Medicine 2008 49 8 1371 1379
34. Devaraj N. K., Keliher E. J., Thurber G. M., Nahrendorf M., Weissleder R., F 18 labeled nanoparticles for in Vivo PET-CT imaging Bioconjugate Chemistry 2009 20 2 397 401
35. Line B. R., Mitra A., Nan A., Ghandehari H., Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates Journal of Nuclear Medicine 2005 46 9 1552 1560
36. Almutairi A., Rossin R., Shokeen M., Hagooly A., Ananth A., Capoccia B., Guillaudeu S., Abendschein D., Anderson C. J., Welch M. J., Frchet J. M. J., Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis Proceedings of the National Academy of Sciences of the United States of America 2009 106 3 685 690
37. Cai W., Chen K., Li Z.-B., Gambhir S. S., Chen X., Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature Journal of Nuclear Medicine 2007 48 11 1862 1870
38. Chen K., Li Z.-B., Wang H., Cai W., Chen X., Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots European Journal of Nuclear Medicine and Molecular Imaging 2008 35 12 2235 2244
39. Ducong F., Pons T., Pestourie C., Hrin L., Thz B., Gombert K., Mahler B., Hinnen F., Khnast B., Doll F., Dubertret B., Tavitian B., Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales Bioconjugate Chemistry 2008 19 9 1921 1926
40. McDevitt M. R., Chattopadhyay D., Kappel B. J., Jaggi J. S., Schiffman S. R., Antczak C., Njardarson J. T., Brentjens R., Scheinberg D. A., Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes Journal of Nuclear Medicine 2007 48 7 1180 1189
41. Saad M., Garbuzenko O. B., Ber E., Chandna P., Khandare J. J., Pozharov V. P., Minko T., Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? Journal of Controlled Release 2008 130 2 107 114
42. Shokeen M., Fettig N. M., Rossin R., Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 52 3 267 277
43. Dobrovolskaia M. A., McNeil S. E., Immunological properties of engineered nanomaterials Nature Nanotechnology 2007 2 8 469 478
44. Lucignani G., Nanoparticles for concurrent multimodality imaging and therapy: the dawn of new theragnostic synergies European Journal of Nuclear Medicine and Molecular Imaging 2009 36 5 869 874
45. Elbayoumi T. A., Pabba S., Roby A., Torchilin V. P., Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents Journal of Liposome Research 2007 17 1 1 14
46. Elbayoumi T. A., Torchilin V. P., Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies European Journal of Nuclear Medicine and Molecular Imaging 2006 33 10 1196 1205
47. Erdogan S., Roby A., Torchilin V. P., Enhanced tumor visualization by -scintigraphy with I111n -labeled polychelating-polymer-containing immunoliposomes Molecular Pharmaceutics 2006 3 5 525 530
48. Hu G., Lijowski M., Zhang H., Partlow K. C., Caruthers S. D., Kiefer G., Gulyas G., Athey P., Scott M. J., Wickline S. A., Lanza G. M., Imaging of Vx-2 rabbit tumors with 3-integrin-targeted I111n nanoparticles International Journal of Cancer 2007 120 9 1951 1957
49. Li L., Wartchow C. A., Danthi S. N., Shen Z., Dechene N., Pease J., Choi H. S., Doede T., Chu P., Ning S., Lee D. Y., Bednarski M. D., Knox S. J., A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated Y90 -labeled nanoparticles International Journal of Radiation Oncology Biology Physics 2004 58 4 1215 1227
50. Liu X., Wang Y., Nakamura K., Kawauchi S., Akalin A., Cheng D., Chen L., Rusckowski M., Hnatowich D. J., Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with I111n Journal of Nuclear Medicine 2009 50 4 582 590
51. Pan X., Wu G., Yang W., Barth R. F., Tjarks W., Lee R. J., Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR Bioconjugate Chemistry 2007 18 1 101 108
52. Shukla S., Wu G., Chatterjee M., Yang W., Sekido M., Diop L. A., Mller R., Sudimack J. J., Lee R. J., Barth R. F., Tjarks W., Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy Bioconjugate Chemistry 2003 14 1 158 167
53. Harrington K. J., Mohammadtaghi S., Uster P. S., Glass D., Peters A. M., Vile R. G., Stewart J. S. W., Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes Clinical Cancer Research 2001 7 2 243 254
54. Carlsson J., Aronsson E. F., Hietala S.-O., Stigbrand T., Tennvall J., Tumour therapy with radionuclides: assessment of progress and problems Radiotherapy and Oncology 2003 66 2 107 117
55. Chen P., Cameron R., Wang J., Vallis K. A., Reilly R. M., Antitumor effects and normal tissue toxicity of I111n -labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts Journal of Nuclear Medicine 2003 44 9 1469 1478
56. Reilly R. M., Chen P., Wang J., Scollard D., Cameron R., Vallis K. A., Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of I111n -DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer Journal of Nuclear Medicine 2006 47 6 1023 1031
57. Reilly R. M., Kiarash R., Cameron R. G., Porlier N., Sandhu J., Hill R. P., Vallis K., Hendler A., Garipy J., I 111 n -labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR Journal of Nuclear Medicine 2000 41 3 429 438
58. Reske S. N., Deisenhofer S., Glutting G., Zlatopolskiy B. D., Morgenroth A., Vogg A. T.J., Buck A. K., Friesen C., I 111 -ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, -, or -radiation-resistant cell lines Journal of Nuclear Medicine 2007 48 6 1000 1007
59. Smith A. M., Duan H., Mohs A. M., Nie S., Bioconjugated quantum dots for in vivo molecular and cellular imaging Advanced Drug Delivery Reviews 2008 60 11 1226 1240
60. Harrington K. J., Lewanski C. R., Stewart J. S. W., Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development Clinical Oncology 2000 12 1 2 15
61. Ogihara-Umeda I., Sasaki T., Kojima S., Nishigori H., Optimal radiolabeled liposomes for tumor imaging Journal of Nuclear Medicine 1996 37 2 326 332
62. Harrington K. J., Lewanski C. R., Stewart J. S. W., Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development Clinical Oncology 2000 12 1 16 24
63. Kleiter M. M., Yu D., Mohammadian L. A., Niehaus N., Spasojevic I., Sanders L., Viglianti B. L., Yarmolenko P. S., Hauck M., Petry N. A., Wong T. Z., Dewhirst M. W., Thrall D. E., A tracer dose of technetium-99m- labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation Clinical Cancer Research 2006 12 22 6800 6807
64. Jensen G. M., Bunch T. H., Conventional liposome performance and evaluation: lessons from the development of Vescan Journal of Liposome Research 2007 17 3-4 121 137
65. Goins B. A., Radiolabeled lipid nanoparticles for diagnostic imaging Expert Opinion on Medical Diagnostics 2008 2 7 853 873
66. Urakami T., Akai S., Katayama Y., Harada N., Tsukada H., Oku N., Novel amphiphilic probes for [ F18 ]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography Journal of Medicinal Chemistry 2007 50 26 6454 6457
67. Oku N., Delivery of contrast agents for positron emission tomography imaging by liposomes Advanced Drug Delivery Reviews 1999 37 13 53 61
68. Marik J., Tartis M. S., Zhang H., Fung J. Y., Kheirolomoom A., Sutcliffe J. L., Ferrara K. W., Long-circulating liposomes radiolabeled with [ F18 ]fluorodipalmitin ([ F18 ]FDP) Nuclear Medicine and Biology 2007 34 2 165 171
69. Seo J. W., Zhang H., Kukis D. L., Meares C. F., Ferrara K. W., A novel method to label preformed liposomes with C64u for positron emission tomography (PET) imaging Bioconjugate Chemistry 2008 19 12 2577 2584
70. Wang H.-E., Yu H.-M., Lu Y.-C., Heish N.-N., Tseng Y.-L., Huang K.-L., Chuang K.-T., Chen C.-H., Hwang J.-J., Lin W.-J., Wang S.-J., Ting G., Whang-Peng J., Deng W.-P., Internal radiotherapy and dosimetric study for I111n / L177u -pegylated liposomes conjugates in tumor-bearing mice Nuclear Instruments and Methods in Physics Research A 2006 569 2 533 537
71. Lee W.-C., Hwang J.-J., Tseng Y.-L., Wang H.-E., Chang Y.-F., Lu Y. C., Ting G., Whang-Peng J., Wang S.-J., Therapeutic efficacy evaluation of I111n -VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts Nuclear Instruments and Methods in Physics Research A 2006 569 2 497 504
72. Chang Y.-J., Chang C.-H., Chang T.-J., Yu C.-Y., Chen L.-C., Jan M.-L., Luo T.-Y., Lee T.-W., Ting G., Biodistribution, pharmacokinetics and microSPECT/CT imaging of R188e -BMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model Anticancer Research 2007 27 4B 2217 2225
73. Chang Y.-J., Chang C.-H., Yu C.-Y., Chang T.-J., Chen L.-C., Chen M.-H., Lee T.-W., Ting G., Therapeutic efficacy and microSPECT/CT imaging of R188e -DXR-liposome in a C26 murine colon carcinoma solid tumor model Nuclear Medicine and Biology 2010 37 1 95 104
74. Emfietzoglou D., Kostarelos K., Sgouros G., An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy Journal of Nuclear Medicine 2001 42 3 499 504
75. Bao A., Goins B., Klipper R., Negrete G., Phillips W. T., R 186 e -liposome labeling using R186e -SNS/S complexes: in vitro stability, imaging, and biodistribution in rats Journal of Nuclear Medicine 2003 44 12 1992 1999
76. Bao A., Goins B., Klipper R., Negrete G., Phillips W. T., Direct T99mc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies Journal of Pharmacology and Experimental Therapeutics 2004 308 2 419 425
77. Phillips W. T., Klipper R., Goins B., Novel method of greatly enhanced delivery of liposomes to lymph nodes Journal of Pharmacology and Experimental Therapeutics 2000 295 1 309 313
78. Wang S. X., Bao A., Herrera S. J., Phillips W. T., Goins B., Santoyo C., Miller F. R., Otto R. A., Intraoperative R186e -liposome radionuclidetherapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model Clinical Cancer Research 2008 14 12 3975 3983
79. Zavaleta C., Goins B., Bao A., Mcmanus L., Mcmahan C. A., Phillips W., Imaging of R186e -liposome therapy in ovarian cancer xenograft model of peritoneal carcinomatosis Journal of Drug Targeting 2008 16 7-8 626 637
80. Chen L.-C., Chang C.-H., Yu C.-Y., Chang Y.-J., Hsu W.-C., Ho C.-L., Yeh C.-H., Luo T.-Y., Lee T.-W., Ting G., Biodistribution, pharmacokinetics and imaging of R188e -BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model Nuclear Medicine and Biology 2007 34 4 415 423
81. Chow T.-H., Lin Y.-Y., Hwang J.-J., Wang H.-E., Tseng Y.-L., Wang S.-J., Liu R.-S., Lin W.-J., Yang C.-S., Ting G., Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model Anticancer Research 2009 29 6 2111 2120
82. Change M.-Y., Seideman J., Sofou S., Enhanced loading efficiency and retention of A225c in rigid liposomes for potential targeted therapy of micrometastases Bioconjugate Chemistry 2008 19 6 1274 1282
83. Sofou S., Kappel B. J., Jaggi J. S., McDevitt M. R., Scheinberg D. A., Sgouros G., Enhanced retention of the -particle-emitting daughters of actinium-225 by liposome carriers Bioconjugate Chemistry 2007 18 6 2061 2067
84. Sofou S., Thomas J. L., Lin H.-Y., McDevitt M. R., Scheinberg D. A., Sgouros G., Engineered liposomes for potential -particle therapy of metastatic cancer Journal of Nuclear Medicine 2004 45 2 253 260
85. Nakamura H., Ueno M., Ban H. S., Nakai K., Tsuruta K., Kaneda Y., Matsumura A., Development of boron nanocapsules for neutron capture therapy Applied Radiation and Isotopes 2009 67 7-8 S84 S87
86. Yanagie H., Maruyama K., Takizawa T., Ishida O., Ogura K., Matsumoto T., Sakurai Y., Kobayashi T., Shinohara A., Rant J., Skvarc J., Ilic R., Kuhne G., Chiba M., Furuya Y., Sugiyama H., Hisa T., Ono K., Kobayashi H., Eriguchi M., Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model Biomedicine and Pharmacotherapy 2006 60 1 43 50
87. Harrington K. J., Rowlinson-Busza G., Syrigos K. N., Vile R. G., Uster P. S., Peters A. M., Stewart J. S. W., Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model Clinical Cancer Research 2000 6 12 4939 4949
88. Huber P. E., Bischof M., Jenne J., Heiland S., Peschke P., Saffrich R., Grne H.-J., Debus J., Lipson K. E., Abdollahi A., Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy Cancer Research 2005 65 9 3643 3655
89. Lammers T., Subr V., Peschke P., Khnlein R., Hennink W. E., Ulbrich K., Kiessling F., Heilmann M., Debus J., Huber P. E., Storm G., Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy British Journal of Cancer 2008 99 6 900 910
90. Chang C.-H., Stabin M. G., Chang Y.-J., Chen L.-C., Chen M.-H., Chang T.-J., Lee T.-W., Ting G., Comparative dosimetric evaluation of nanotargeted R188e -(DXR)- liposome for internal radiotherapy Cancer Biotherapy and Radiopharmaceuticals 2008 23 6 749 758
91. Chen L.-C., Chang C.-H., Yu C.-Y., Chang Y.-J., Wu Y.-H., Lee W.-C., Yeh C.-H., Lee T.-W., Ting G., Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of R188e -DXR-liposome in C26 colon carcinoma ascites mice model Nuclear Medicine and Biology 2008 35 8 883 893
92. Chow T.-H., Lin Y.-Y., Hwang J.-J., Wang H.-E., Tseng Y.-L., Pang V. F., Wang S.-J., Whang-Peng J., Ting G., Diagnostic and therapeutic evaluation of I111n -vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model Nuclear Medicine and Biology 2008 35 5 623 634
93. Lin Y.-Y., Li J.-J., Chang C.-H., Lu Y.-C., Hwang J.-J., Tseng Y.-L., Lin W.-J., Ting G., Wang H.-E., Evaluation of pharmacokinetics of I111n -labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model Cancer Biotherapy and Radiopharmaceuticals 2009 24 4 453 460
94. Kostarelos K., Emfietzoglou D., Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: toward liposome-targeted therapeutic radiopharmaceuticals Anticancer Research 2000 20 5A 3339 3345
95. Syme A. M., McQuarrie S. A., Middleton J. W., Fallone B. G., Dosimetric model for intraperitoneal targeted liposomal radioimmunotherapy of ovarian cancer micrometastases Physics in Medicine and Biology 2003 48 10 1305 1320
96. Huwyler J., Drewe J., Krhenbhl S., Tumor targeting using liposomal antineoplastic drugs International Journal of Nanomedicine 2008 3 1 21 29
97. Park J. W., Benz C. C., Martin F. J., Future directions of liposome- and immunoliposome-based cancer therapeutics Seminars in Oncology 2004 31 13 196 205
98. Cheon J., Lee J.-H., Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology Accounts of Chemical Research 2008 41 12 1630 1640
99. Elbayoumi T. A., Torchilin V. P., Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines European Journal of Pharmaceutical Sciences 2007 32 3 159 168
100. Kamaly N., Kalber T., Thanou M., Bell J. D., Miller A. D., Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging Bioconjugate Chemistry 2009 20 4 648 655
101. Lukyanov A. N., Elbayoumi T. A., Chakilam A. R., Torchilin V. P., Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody Journal of Controlled Release 2004 100 1 135 144
102. Diagaradjane P., Orenstein-Cardona J. M., Coln-Casasnovas N. E., Deorukhkar A., Shentu S., Kuno N., Schwartz D. L., Gelovani J. G., Krishnan S., Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe Clinical Cancer Research 2008 14 3 731 741
103. Koole R., van Schooneveld M. M., Hilhorst J., Castermans K., Cormode D. P., Strijkers G. J., Doneg C. D. M., Vanmaekelbergh D., Griffioen A. W., Nicolay K., Fayad Z. A., Meijerink A., Mulder W. J. M., Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging Bioconjugate Chemistry 2008 19 12 2471 2479
104. van Schooneveld M. M., Vucic E., Koole R., Zhou Y., Stocks J., Cormode D. P., Tang C. Y., Gordon R. E., Nicolay K., Meijerink A., Fayad Z. A., Mulder W. J. M., Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation Nano Letters 2008 8 8 2517 2525
105. Tasciotti E., Liu X., Bhavane R., Plant K., Leonard A. D., Price B. K., Cheng M. M.-C., Decuzzi P., Tour J. M., Robertson F., Ferrari M., Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications Nature Nanotechnology 2008 3 3 151 157
106. Ganta S., Amiji M., Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells Molecular Pharmaceutics 2009 6 3 928 939
107. Garnett M. C., Kallinteri P., Nanomedicines and nanotoxicology: some physiological principles Occupational Medicine 2006 56 5 307 311
108. Nel A., Xia T., Mdler L., Li N., Toxic potential of materials at the nanolevel Science 2006 311 5761 622 627
109. Dobrovolskaia M. A., Germolec D. R., Weaver J. L., Evaluation of nanoparticle immunotoxicity Nature Nanotechnology 2009 4 7 411 414
110. Vega-Villa K. R., Takemoto J. K., Yez J. A., Remsberg C. M., Forrest M. L., Davies N. M., Clinical toxicities of nanocarrier systems Advanced Drug Delivery Reviews 2008 60 8 929 938
111. Fisher D. R., Shen S., Meredith R. F., MIRD dose estimate report No. 20: radiation absorbed-dose estimates for I111n-and Y90 -ibritumomab tiuxetan Journal of Nuclear Medicine 2009 50 4 644 652